• Filter By:
• Specialty
• Source
• Condition
• Cancer
• Infectious Disease
• Drug
• Training
• Management
• Procedure
• Therapy
• Vaccine
• Nutrition
• Country

Survey of Integrative Medicine in Myeloproliferative Neoplasms (The SIMM Study-2)
Conclusion:In a geographically diverse MPN patient population, and when adjusting for healthy lifestyle practices overall, patterns of lower symptom burden, fatigue, depression, and higher QoL were revealed with integrative medicine utilization. Although limited by gender discrepancy and patient reported data, this study may offer a foundation to structure future integrative medicine trials to complement standard therapies in MPN patients.DisclosuresGowin: Incyte: Consultancy, Other: Scientific Advisory Board, Speakers Bureau. Mesa: UT Health San Antonio - Mays Cancer Center: Employment; Promedior: Research Funding; NS Pha...
Source: Blood - November 21, 2018 Category: Hematology Authors: Gowin, K. L., Langlais, B. T., Millstine, D., Kosiorek, H. E., Huberty, J., Eckert, R., Mesa, R. A. Tags: 634. Myeloproliferative Syndromes: Clinical: Poster II Source Type: research

Prescription of Complementary and Alternative Medicine (CAM) in an Italian Cohort of Pediatric Headache Patients (P03.115)
CONCLUSIONS: Our study shows that CAM is widely used among pediatric headache patients, and physicians are mostly unaware of prescription. Further studies are required to investigate safety and efficacy of CAM, as a possible side-medicine to conventional pharmacological approach.Disclosure: Dr. Colombo has nothing to disclose. Dr. Dalla Libera has nothing to disclose. Dr. Pavan has nothing to disclose. Dr. Comi has received personal compensation for activities with Novartis, Teva Neuroscience, Sanofi-Aventis Pharmaceuticals, Inc., Merck Serono, and Bayer Schering.
Source: Neurology - February 14, 2013 Category: Neurology Authors: Colombo, B., Dalla Libera, D., Pavan, G., Comi, G. Tags: P03 Headache: Epidemiology Source Type: research